share_log

港股公告掘金 | 诺诚健华与FDA就奥布替尼治疗原发进展型多发性硬化症(PPMS)患者启动III期研究达成一致

Hong Kong Stock Exchange Announcement: Innocare and FDA have reached an agreement to initiate Phase III study for the treatment of primary progressive multiple sclerosis (PPMS) patients with Obrutinib.

Zhitong Finance ·  Sep 8 06:48

Nuochengjianhua and FDA agree to launch phase III study on the treatment of patients with primary progressive multiple sclerosis (PPMS) with obutinib; JD Logistics and Dada signed a freight service framework agreement

Important matters:

Alpha Enterprises (00948) plans to subscribe for 48.4775 million AHF shares at AU$0.9696 million

China Glass (03300) plans to spend about 17.7095 million US dollars to acquire land use rights for a plot of land in Egypt

Huiju Technology (01729) and its controlling shareholder Lixun Precision set up a joint venture Time Interconnect Singapore Pte. Ltd.

Chenghui New Energy, a subsidiary of Chenghui International (01094), plans to increase the capital of the joint venture by 28.5 million yuan

Jiayao Holdings (01626) plans to sell 70% of Giant Harmony Limited's shares for $0.115 billion

JD Logistics (02618) signs freight service framework agreement with Dada

Nuochengjianhua (09969) and FDA agree to launch phase III study on the treatment of patients with primary progressive multiple sclerosis (PPMS) with obutinib

Operating performance:

The cumulative contract sales amount of Poly Real Estate Group (00119) in the first 8 months was about 36.8 billion yuan, a year-on-year decrease of 13.6%

GAC Group (02238): Vehicle sales in August were 0.1482 million vehicles

Times China Holdings (01233)'s cumulative contract sales for the first 8 months were 5.696 billion yuan, down 49% year on year

Xincheng Development (01030) contract sales amount for the first 8 months was about 29.542 billion yuan, a year-on-year decrease of 45.75%

Zhongliang Holdings (02772)'s cumulative contract sales for the first 8 months were about 12.32 billion yuan, a year-on-year decrease of 51.25%

Hongyang Real Estate (01996)'s cumulative contract sales amount for the first 8 months was 6.07 billion yuan, a year-on-year decrease of 64.11%

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment